查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827748

2025年活细胞成像全球市场报告

Live Cell Imaging Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，活细胞成像市场快速扩张，市场规模从2024年的49.9亿美元成长至2025年的56.7亿美元，复合年增长率达13.7%。预测期内的成长主要源自于药物研发、癌症研究、生物技术和生物製药、临床应用以及细胞和分子生物学等领域。

预计未来几年活细胞成像市场规模将快速成长，到2029年将达到98.6亿美元，复合年增长率为14.8%。预测期内的成长可归因于感染疾病研究、个人化医疗的采用、环境和生态研究、感染疾病研究以及免疫疗法的发展。预测期内的主要趋势包括3D和4D成像、超高解析度显微镜、高内涵筛检、活细胞追踪软体以及微流体设备。

活细胞成像是指对活细胞进行体内成像，用于诊断和治疗目的。相关仪器能够详细观察细胞内部结构和细胞过程，有助于更深入了解细胞生物学。

活细胞影像产品主要分为仪器、耗材和软体。活细胞影像技术包括延时显微镜、光漂白后萤光恢復 (FRAP)、萤光共振能量转移 (FRET) 和高内涵筛检(HCS)。活细胞成像应用范围广泛，包括细胞生物学、发育生物学、干细胞和药物研发。它被製药和生物技术公司、学术研究机构以及委外研发机构(CRO) 广泛采用。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供活细胞成像市场统计数据，例如全球活细胞成像行业规模、各地区市场份额、竞争对手的市场份额、详细的活细胞成像细分市场、市场趋势和商业机会，以及您在活细胞成像行业取得成功所需的数据。本活细胞成像市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全方位观点。

未来五年14.8%的预测成长率与我们先前对该市场的预测保持不变。这一下降主要源自于美国与其他国家之间关税的影响。美国可能会透过对来自荷兰和丹麦等主要地区的环境控制室和高灵敏度电荷耦合元件 (CCD) 相机征收关税，直接感受到这一影响。

预计预测期内，癌症发生率的上升将推动活细胞成像市场的成长。癌症是全球第二大死因，每年六分之一的死亡是由癌症引起的。例如，2024 年 7 月，专注于提供全面的健康和福利数据和分析的澳洲政府机构澳洲健康与福利研究所报告称，澳洲确诊的癌症病例数将从 2021 年的 156,781 例增加到 2022 年的 160,570 例，同比增长 3,789 例。活细胞成像技术对于癌症免疫疗法的进步和检验至关重要，因为它能够可视化、表征和评估活细胞中的生物过程。因此，癌症发生率的上升促进了活细胞成像市场的成长。

个人化医疗需求的蓬勃发展推动着活细胞成像市场的发展。个人化医疗透过根据每位患者独特的基因、分子和细胞特征，为其量身定制治疗决策、干预措施和药物疗法，彻底改变了治疗方案。这种方法对于活细胞成像至关重要，它能够根据个体特定的生物学特征量身定制治疗方案。例如，到2022年10月，将有超过75,000种基因检测产品和超过300种个人化医疗产品，这标誌着个人化医疗的普及度不断提高，并最终推动活细胞成像市场的成长。

活细胞成像市场成长的一个潜在限制因素是熟练专业人员的短缺。活细胞成像技术的复杂性要求具备高技能、精通理解和研究细胞功能的专业人员。报告显示，未来十年，英国和欧洲将面临严重的实验室技能短缺，其中医疗实验室将受到最大影响。盖兹比基金会的研究表明，到2030年底，英国将需要额外70万名技术人员来支持其经济发展。熟练专业人员的短缺可能会在未来几年阻碍市场成长。

活细胞成像市场的主要企业正透过开发创新产品来提升收益。新一代活细胞影像分析系统 CytoSMART Omni FL 就是一个显着的例子。该系统首次将红色和绿色萤光通道引入 CytoSMART Omni 产品线，能够在各种透明细胞培养容器中创建高品质的明场和高通量活细胞萤光影像。总部位于荷兰的 CytoSMART Technologies 于 2022 年 4 月推出了这款多功能且灵活的设备，展现了其在活细胞成像市场的持续创新。

2022年3月，美国生命科学公司Axion BioSystems收购了CytoSMART Technologies，具体金额未揭露。此次策略性收购旨在进一步拓展Axion在干细胞研究和免疫肿瘤学领域的业务，并充分利用CytoSMART Technologies在活细胞成像领域的专业知识。

活细胞成像市场的主要参与者包括 Leica Microsystems GmbH、Olympus Corporation、Sigma-Aldrich Corporation、PerkinElmer Inc.、GE Healthcare Technologies Inc.、Carl Zeiss Meditec AG、Becton Dickinson and Company、Molecular Devices LLC、Bruker Corporation、Sartorius AG、Oxford Instru​​yal Inc. Biotech Corp.、CYTENA GmbH、Nanolive SA、Abberior GmbH、Phase Holographic Imaging AB、Cytoskeleton Inc.、Corning Incorporated、KEYENCE Corporation、Aligned Genetics Inc.、Axion BioSystems Inc.、Bio-Rad Laboratories Inc.、Nanob Technologies Inc.、Danok Technologies Inc.、Biocus、Sage Technologies Inc.、Nanob Technologies Inc.、C. Technologies Inc.Y.、Y.Sa Technologies Inc.）

2024 年，北美是活细胞成像市场最大的地区。活细胞成像市场分析报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

活细胞成像市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

活细胞成像市场涵盖光学显微镜、物镜、配件和试剂的销售。该市场的价值指的是“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球活细胞成像：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球活细胞成像市场：成长率分析
  • 全球活细胞成像市场表现：规模与成长，2019-2024
  • 全球活细胞成像市场预测：规模与成长，2024-2029 年，2034 年
  • 全球活细胞成像：总目标市场（TAM）

第六章 市场细分

  • 全球活细胞成像市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 耗材
  • 软体
  • 全球活细胞成像市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 延时显微镜
  • 光漂白后萤光恢復（FRAP）
  • 萤光共振能量转移（FRET）
  • 高内涵筛检（HCS）
  • 其他技术
  • 全球活细胞成像市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 细胞生物学
  • 发育生物学
  • 干细胞与药物发现
  • 其他用途
  • 全球活细胞成像市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 製药和生物技术公司
  • 学术研究机构
  • 合约研究组织（CRO）
  • 全球活细胞成像市场：按设备类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 显微镜
  • 影像系统
  • 光片显微镜
  • 摄影机和检测器
  • 全球活细胞成像市场：按耗材（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 细胞培养板和培养皿
  • 试剂和染色剂
  • 媒体和补充资料
  • 影像感测器
  • 全球活细胞成像市场：按软体（类型）细分、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 影像分析软体
  • 资料管理软体
  • 视觉化软体
  • 影像处理工具

第七章 区域和国家分析

  • 全球活细胞成像市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球活细胞成像市场：按国家、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 活细胞成像市场：竞争格局
  • 活细胞成像市场：公司简介
    • Leica Microsystems GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Leica Microsystems GmbH Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Carl Zeiss Meditec AG
  • Becton Dickinson and Company
  • Molecular Devices LLC
  • Bruker Corporation
  • Sartorius AG
  • Oxford Instruments plc
  • BioTek Instruments Inc.
  • Etaluma Inc.
  • CytoSMART Technologies BV
  • Blue-Ray Biotech Corp.
  • CYTENA GmbH
  • Nanolive SA
  • Abberior GmbH
  • Phase Holographic Imaging AB
  • Cytoskeleton Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年活细胞影像市场：提供新机会的国家
  • 2029年活细胞成像市场：细分领域带来新机会
  • 2029年活细胞影像市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21727u

Live cell imaging involves the in vivo imaging of living cells, serving diagnostic and treatment purposes. The associated equipment enables a detailed examination of internal structures and cellular processes, contributing to a deeper understanding of cell biology.

Live cell imaging products are primarily categorized into equipment, consumables, and software. The technologies utilized in live cell imaging encompass time-lapse microscopy, fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), among others. Applications of live cell imaging extend to cell biology, developmental biology, stem cell and drug discovery, and various other fields. It is widely employed in sectors such as pharmaceutical and biotechnology companies, academic and research institutes, as well as contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The live cell imaging market research report is one of a series of new reports from The Business Research Company that provides live cell imaging market statistics, including live cell imaging industry global market size, regional shares, competitors with a live cell imaging market share, detailed live cell imaging market segments, market trends and opportunities, and any further data you may need to thrive in the live cell imaging industry. This live cell imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The live cell imaging market size has grown rapidly in recent years. It will grow from $4.99 billion in 2024 to $5.67 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to drug discovery and development, cancer research, biotechnology and biopharmaceuticals, clinical applications, cellular and molecular biology.

The live cell imaging market size is expected to see rapid growth in the next few years. It will grow to $9.86 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to infectious disease research, adoption of personalized medicine, environmental and ecological research, infectious disease research, immunotherapy development. Major trends in the forecast period include 3D and 4d imaging, super-resolution microscopy, high-content screening, live-cell tracking software, microfluidic devices.

The forecast of 14.8% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on environmental control chambers and high-sensitivity charge-coupled device (CCD) cameras, sourced from key regions such as the Netherlands and Denmark, which could lead to compromised cellular research and increased costs for biological imaging systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is anticipated to drive the growth of the live cell imaging market during the forecast period. Cancer is the second leading cause of death globally, accounting for one in every six fatalities each year. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia focused on providing comprehensive health and welfare data and analysis, reported that the number of cancer cases diagnosed in Australia rose from 156,781 in 2021 to 160,570 in 2022, reflecting an increase of 3,789 cases over that year. Live cell imaging technology is essential for advancing and validating cancer immunotherapy by enabling the visualization, characterization, and evaluation of biological processes in living cells. Consequently, the rising incidence of cancer contributes to the growth of the live cell imaging market.

The burgeoning demand for personalized medicine is set to propel the live cell imaging market forward. Personalized medicine revolutionizes medical treatment by tailoring decisions, interventions, and drug therapies to the individual patient based on their unique genetic, molecular, and cellular characteristics. This approach proves invaluable for live cell imaging, enabling customization of medical treatments to an individual's specific biological traits. For example, by October 2022, there were over 75,000 genetic testing products and 300 personalized medicines, showcasing the increasing adoption of personalized medicine and, consequently, driving the growth of the live cell imaging market.

The potential constraint in the growth of the live cell imaging market is the lack of skilled professionals. The intricate nature of live cell imaging technology demands highly skilled professionals proficient in understanding and studying cellular functions. Reports indicate a severe shortage of laboratory skills in the UK and Europe over the next decade, with medical laboratories among the most affected. The Gatsby Foundation's research suggests that the UK will need an additional 700,000 technicians by the end of 2030 to support the economy. This shortage of skilled professionals poses a potential impediment to market growth in the coming years.

Leading companies in the live cell imaging market are driving revenue through the development of innovative products. The CytoSMART Omni FL, a next-generation live-cell imaging analysis system, is a notable example. This system introduces red and green fluorescence channels into the CytoSMART Omni product line for the first time, enabling the production of high-quality brightfield or high-throughput fluorescence images of living cells in various transparent cell culture vessels. CytoSMART Technologies, a Netherlands-based company, launched this versatile and flexible device in April 2022, showcasing the continuous innovation in the live cell imaging market.

In March 2022, Axion BioSystems, a US-based life sciences company, acquired CytoSMART Technologies for an undisclosed amount. This strategic acquisition aims to facilitate Axion's expansion into stem cell research and immuno-oncology, leveraging the expertise of CytoSMART Technologies in the field of live cell imaging.

Major companies operating in the live cell imaging market include Leica Microsystems GmbH, Olympus Corporation, Sigma-Aldrich Corporation, PerkinElmer Inc., GE Healthcare Technologies Inc., Carl Zeiss Meditec AG, Becton Dickinson and Company, Molecular Devices LLC, Bruker Corporation, Sartorius AG, Oxford Instruments plc, BioTek Instruments Inc., Etaluma Inc., CytoSMART Technologies B.V., Blue-Ray Biotech Corp., CYTENA GmbH, Nanolive SA, Abberior GmbH, Phase Holographic Imaging AB, Cytoskeleton Inc., Corning Incorporated, KEYENCE Corporation, Aligned Genetics Inc., Axion BioSystems Inc., Bio-Rad Laboratories Inc., NanoEnTek Inc., Danaher Corporation, Agilent Technologies Inc., Leinco Technologies, Phasefocus Ltd.

North America was the largest region in the live cell imaging market in 2024. The regions covered in the live cell imaging market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the live cell imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The live cell imaging market consists of sales of light microscopes, objective lenses, accessories, and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Live Cell Imaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on live cell imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for live cell imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The live cell imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Equipment; Consumable; Software
  • 2) By Technology: Time-Lapse Microscopy; Fluorescence Recovery After Photobleaching (FRAP); Fluorescence Resonance Energy Transfer (FRET); High Content Screening (HCS); Other Technologies
  • 3) By Application: Cell Biology; Developmental Biology; Stem Cell and Drug Discovery; Other Applications
  • 4) By End-User: Pharmaceutical and Biotechnology Companies; Academic and Research Institutes; Contract Research Organizations (CROs)
  • Subsegments:
  • 1) By Equipment: Microscopes; Imaging Systems; Light Sheet Microscopes; Cameras And Detectors
  • 2) By Consumable: Cell Culture Plates And Dishes; Reagents And Stains; Media And Supplements; Imaging Sensors
  • 3) By Software: Image Analysis Software; Data Management Software; Visualization Software; Image Processing Tools
  • Companies Mentioned: Leica Microsystems GmbH; Olympus Corporation; Sigma-Aldrich Corporation; PerkinElmer Inc.; GE Healthcare Technologies Inc.; Carl Zeiss Meditec AG; Becton Dickinson and Company; Molecular Devices LLC; Bruker Corporation; Sartorius AG; Oxford Instruments plc; BioTek Instruments Inc.; Etaluma Inc.; CytoSMART Technologies B.V.; Blue-Ray Biotech Corp.; CYTENA GmbH; Nanolive SA; Abberior GmbH; Phase Holographic Imaging AB; Cytoskeleton Inc.; Corning Incorporated; KEYENCE Corporation; Aligned Genetics Inc.; Axion BioSystems Inc.; Bio-Rad Laboratories Inc.; NanoEnTek Inc.; Danaher Corporation; Agilent Technologies Inc.; Leinco Technologies; Phasefocus Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Live Cell Imaging Market Characteristics

3. Live Cell Imaging Market Trends And Strategies

4. Live Cell Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Live Cell Imaging Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Live Cell Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Live Cell Imaging Market Growth Rate Analysis
  • 5.4. Global Live Cell Imaging Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Live Cell Imaging Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Live Cell Imaging Total Addressable Market (TAM)

6. Live Cell Imaging Market Segmentation

  • 6.1. Global Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Equipment
  • Consumable
  • Software
  • 6.2. Global Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Time-Lapse Microscopy
  • Fluorescence Recovery After Photobleaching (FRAP)
  • Fluorescence Resonance Energy Transfer (FRET)
  • High Content Screening (HCS)
  • Other Technologies
  • 6.3. Global Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Biology
  • Developmental Biology
  • Stem Cell and Drug Discovery
  • Other Applications
  • 6.4. Global Live Cell Imaging Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • 6.5. Global Live Cell Imaging Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microscopes
  • Imaging Systems
  • Light Sheet Microscopes
  • Cameras And Detectors
  • 6.6. Global Live Cell Imaging Market, Sub-Segmentation Of Consumable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Culture Plates And Dishes
  • Reagents And Stains
  • Media And Supplements
  • Imaging Sensors
  • 6.7. Global Live Cell Imaging Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Image Analysis Software
  • Data Management Software
  • Visualization Software
  • Image Processing Tools

7. Live Cell Imaging Market Regional And Country Analysis

  • 7.1. Global Live Cell Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Live Cell Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Live Cell Imaging Market

  • 8.1. Asia-Pacific Live Cell Imaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Live Cell Imaging Market

  • 9.1. China Live Cell Imaging Market Overview
  • 9.2. China Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Live Cell Imaging Market

  • 10.1. India Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Live Cell Imaging Market

  • 11.1. Japan Live Cell Imaging Market Overview
  • 11.2. Japan Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Live Cell Imaging Market

  • 12.1. Australia Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Live Cell Imaging Market

  • 13.1. Indonesia Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Live Cell Imaging Market

  • 14.1. South Korea Live Cell Imaging Market Overview
  • 14.2. South Korea Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Live Cell Imaging Market

  • 15.1. Western Europe Live Cell Imaging Market Overview
  • 15.2. Western Europe Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Live Cell Imaging Market

  • 16.1. UK Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Live Cell Imaging Market

  • 17.1. Germany Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Live Cell Imaging Market

  • 18.1. France Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Live Cell Imaging Market

  • 19.1. Italy Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Live Cell Imaging Market

  • 20.1. Spain Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Live Cell Imaging Market

  • 21.1. Eastern Europe Live Cell Imaging Market Overview
  • 21.2. Eastern Europe Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Live Cell Imaging Market

  • 22.1. Russia Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Live Cell Imaging Market

  • 23.1. North America Live Cell Imaging Market Overview
  • 23.2. North America Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Live Cell Imaging Market

  • 24.1. USA Live Cell Imaging Market Overview
  • 24.2. USA Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Live Cell Imaging Market

  • 25.1. Canada Live Cell Imaging Market Overview
  • 25.2. Canada Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Live Cell Imaging Market

  • 26.1. South America Live Cell Imaging Market Overview
  • 26.2. South America Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Live Cell Imaging Market

  • 27.1. Brazil Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Live Cell Imaging Market

  • 28.1. Middle East Live Cell Imaging Market Overview
  • 28.2. Middle East Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Live Cell Imaging Market

  • 29.1. Africa Live Cell Imaging Market Overview
  • 29.2. Africa Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Live Cell Imaging Market Competitive Landscape And Company Profiles

  • 30.1. Live Cell Imaging Market Competitive Landscape
  • 30.2. Live Cell Imaging Market Company Profiles
    • 30.2.1. Leica Microsystems GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Leica Microsystems GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Live Cell Imaging Market Other Major And Innovative Companies

  • 31.1. Carl Zeiss Meditec AG
  • 31.2. Becton Dickinson and Company
  • 31.3. Molecular Devices LLC
  • 31.4. Bruker Corporation
  • 31.5. Sartorius AG
  • 31.6. Oxford Instruments plc
  • 31.7. BioTek Instruments Inc.
  • 31.8. Etaluma Inc.
  • 31.9. CytoSMART Technologies B.V.
  • 31.10. Blue-Ray Biotech Corp.
  • 31.11. CYTENA GmbH
  • 31.12. Nanolive SA
  • 31.13. Abberior GmbH
  • 31.14. Phase Holographic Imaging AB
  • 31.15. Cytoskeleton Inc.

32. Global Live Cell Imaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Live Cell Imaging Market

34. Recent Developments In The Live Cell Imaging Market

35. Live Cell Imaging Market High Potential Countries, Segments and Strategies

  • 35.1 Live Cell Imaging Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Live Cell Imaging Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Live Cell Imaging Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer